Listed
Stock Code: 003520
| Company Name | 영진약품(주) |
| English Name | YUNGJIN PHARM. CO., LTD |
| Business Reg. No. | 2188100352 |
| CEO | 이기수 |
| Address | 서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층 |
| Industry | 의약품 제조업 |
| Industry Code | 212 |
| Established | 19620716 |
| Phone | 02-2041-8200 |
| Website | www.yungjin.co.kr |
| Regular Employees | 622persons |
| Corp. Reg. No. | 1101110043127 |
Revenue CAGR +8.7%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 2,520B | 2,349B | 2,184B | 1,961B |
| Operating Profit | 87B | 31B | -74B | -139B |
| Net Profit | 12B | -39B | -220B | -116B |
| Total Assets | 2,343B | 2,266B | 2,031B | 1,941B |
| Total Liabilities | 1,445B | 1,370B | 1,132B | 892B |
| Total Equity | 898B | 896B | 899B | 1,049B |
▲ 16.4%
▲ 244.4%
▲ 213.8%
▲ 32.6%
▲ 110.3%
| Name | Position | Role |
|---|---|---|
| 이기수 | 사내이사 | 총괄 |
| 김원섭 | 사외이사 | 사외이사 |
| 김붕년 | 사외이사 | 사외이사 |
| 고영엽 | 사외이사 | 사외이사 |
| 이동재 | 기타비상무이사 | 기타비상무이사 |
| 이웅규 | 미등기 | 사업관리 총괄 |
| 양웅열 | 미등기 | 영업마케팅본부 총괄 |
| 박병호 | 미등기 | 재무실 총괄 |
| 황현준 | 미등기 | 개발본부 총괄 |
| NPS Subscribers | 614persons |
| CEO | 이기수 |
| Est. Avg. Annual Salary | 6,41510K (53510K/mo) |
| Hired (12 mo) | +12persons |
| Left (12 mo) | -5persons |
| Net Change (12 mo) | +7persons |
| NPS Join Date | 1988-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
1 Additional Data Sources
{
"address": "서울특별시 송파구 올림픽로35다길",
"brno": "218810****",
"cappedWarning": false,
"companyName": "영진약품(주)",
"estimatedAvgAnnualSalary": 64148076,
"estimatedAvgMonthlySalary": 5345673,
"fetchedAt": "2026-03-05T11:41:30.361Z",
"industryCode": "242301",
"industryName": "완제 의약품 제조업",
"joinDate": "19880101",
"last12MonthsHired": 12,
"last12MonthsLeft": 5,
"last12MonthsNetChange": 7,
"leaveDate": null,
"monthlyPensionAmount": 311813120,
"monthlyTrend": [
{
"lostSubscribers": 5,
"newSubscribers": 12,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6333331",
"status": "1",
"styleCode": "1",
"subscriberCount": 614,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 7/7
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |